Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1 Patients”

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00144833
What this trial is testing

Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects

Who this might be right for
HIV-1
GlaxoSmithKline 150
Not applicableStudy completedNCT04133012
What this trial is testing

Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 20
Not applicableStudy completedNCT00001117
What this trial is testing

Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Ended earlyNCT03493568
What this trial is testing

Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE)

Who this might be right for
HIV-1-infection
IRCCS San Raffaele 100
Post-approval studies (Phase 4)Study completedNCT01989910
What this trial is testing

Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients

Who this might be right for
HIV-1 Infection
Taipei Veterans General Hospital, Taiwan 107
Post-approval studies (Phase 4)UnknownNCT03774108
What this trial is testing

Metformin and Systemic Inflammation in HIV

Who this might be right for
PreDiabetesHIV-1-infection
Hospital Civil de Guadalajara 40
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05527418
What this trial is testing

Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection

Who this might be right for
Recent HIV-1 Infection
Eva Bonfill 24
Testing effectiveness (Phase 2)Ended earlyNCT00513513
What this trial is testing

TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 7
Large-scale testing (Phase 3)Study completedNCT00323544
What this trial is testing

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

Who this might be right for
HIV Infections
Gilead Sciences 220
Not applicableStudy completedNCT00672932
What this trial is testing

Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients

Who this might be right for
HIV Infections
University of California, San Francisco 18
Large-scale testing (Phase 3)Study completedNCT00144287
What this trial is testing

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

Who this might be right for
HIV Infections
Boehringer Ingelheim 255
Not applicableStudy completedNCT00001089
What this trial is testing

HIV and Cytomegalovirus (CMV) in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Testing effectiveness (Phase 2)Study completedNCT00530920
What this trial is testing

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 85
Post-approval studies (Phase 4)Study completedNCT00127959
What this trial is testing

Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection

Who this might be right for
HIV InfectionsHepatitis B
International Antiviral Therapy Evaluation Center 24
Testing effectiveness (Phase 2)Study completedNCT02473328
What this trial is testing

Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients

Who this might be right for
HIV-1 Infection
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 90
Testing effectiveness (Phase 2)UnknownNCT00002451
What this trial is testing

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 8
Post-approval studies (Phase 4)Ended earlyNCT01602822
What this trial is testing

Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV

Who this might be right for
HIV
Kenneth H. Mayer, MD 11
Large-scale testing (Phase 3)Study completedNCT00808002
What this trial is testing

Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 30
Early research (Phase 1)Active Not RecruitingNCT02500849
What this trial is testing

Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients

Who this might be right for
HIV
City of Hope Medical Center 12
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation